NCT03123861View on ClinicalTrials.gov

Gabapentin for Postop Pain After SSLF

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

July 25, 2020

Study Completion Date

July 25, 2020

Conditions
Pelvic Organ Prolapse
Interventions
DRUG

Gabapentin

Patients randomized to this arm will receive 2 weeks of gabapentin post-operatively.

DRUG

Placebo oral capsule

Patients randomized to this arm will receive 2 weeks of placebo post-operatively..

Trial Locations (1)

27599

UNC Chapel Hill, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT03123861 - Gabapentin for Postop Pain After SSLF | Biotech Hunter | Biotech Hunter